Advances in dissolution instrumentation and their practical applications

Abstract The rising demands on discriminatory and prediction abilities of dissolution methods and the increasing complexity of new drug products are the main driving forces of the progress in this field. The research moves forward as imperfections and shortcomings of classical methods are being described, and where the capabilities of the contemporary methods are insufficient, new methods are being developed. The review discusses these advances with respect to the issues that currently draw the most attention, i.e. correct simulation of hydrodynamics and stress forces, maintenance of sink conditions, study of precipitation, use of biorelevant media and the employment of more physiologically relevant methods in general.

[1]  David C. Sperry,et al.  Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model. , 2006, Journal of Pharmacy and Science.

[2]  A. Beckett,et al.  Improved Hydrodynamics for USP Apparatus 2 , 1996 .

[3]  J. Crison,et al.  Predictive models for drugs exhibiting negative food effects based on their biopharmaceutical characteristics , 2011, Drug development and industrial pharmacy.

[4]  N. Fotaki,et al.  Biorelevant dissolution methods and their applications in in vitroin vivo correlations for oralformulations , 2010 .

[5]  Raimar Löbenberg,et al.  Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Dissolution Behavior of Glibenclamide , 2000, Pharmaceutical Research.

[6]  J. Polli,et al.  Prediction of dissolution-absorption relationships from a dissolution/Caco-2 system. , 1999, International journal of pharmaceutics.

[7]  Xin He,et al.  Application of an in vitro DDASS to evaluate oral absorption of two chemicals simultaneously: establishment of a level A in vitro–in vivo correlation , 2012, Drug development and industrial pharmacy.

[8]  G. Duchateau,et al.  Food-dependent disintegration of immediate release fosamprenavir tablets: in vitro evaluation using magnetic resonance imaging and a dynamic gastrointestinal system. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  W. Butler,et al.  A flow-through dissolution method for a two component drug formulation where the actives have markedly differing solubility properties , 1998 .

[10]  Vivian Gray,et al.  The Science of USP 1 and 2 Dissolution: Present Challenges and Future Relevance , 2009, Pharmaceutical Research.

[11]  K. Iseki,et al.  Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract. , 2001, International journal of pharmaceutics.

[12]  Clive G. Wilson,et al.  Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  N. Fotaki,et al.  Biorelevant Dissolution Methods and Their Applications in In Vitro- In Vivo Correlations for Oral Formulations~!2009-09-14~!2009-11-02~!2010-04-29~! , 2010 .

[14]  James A. Rogers,et al.  Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. II. Improved in vitro-in vivo correlation using a two-phase dissolution test , 1997 .

[15]  Zongming Gao Development of a Continuous Dissolution/Absorption System—a Technical Note , 2012, AAPS PharmSciTech.

[16]  P. Gao,et al.  Dissolution of poorly water-soluble drugs in biphasic media using USP 4 and fiber optic system , 2009 .

[17]  Rolf Daniels,et al.  Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  G. Amidon,et al.  Mechanistic analysis of solute transport in an in vitro physiological two‐phase dissolution apparatus , 2012, Biopharmaceutics & drug disposition.

[19]  R. Fisher,et al.  Gastric emptying of a non‐digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[20]  R. Parikh,et al.  A Novel Multicompartment Dissolution Apparatus for Evaluation of Floating Dosage Form Containing Poorly Soluble Weakly Basic Drug , 2006 .

[21]  Geert Verreck,et al.  Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  Eric Beyssac,et al.  A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[23]  P. Kulinowski,et al.  Magnetic Resonance Imaging and Image Analysis for Assessment of HPMC Matrix Tablets Structural Evolution in USP Apparatus 4 , 2010, Pharmaceutical Research.

[24]  C. Goodman United States Pharmacopeial Convention , 1988 .

[25]  J. Brasseur,et al.  A Novel in Vitro and Numerical Analysis of Shear-Induced Drug Release from Extended-Release Tablets in the Fed Stomach , 2005, Pharmaceutical Research.

[26]  J. Dressman,et al.  Forecasting the Oral Absorption Behavior of Poorly Soluble Weak Bases Using Solubility and Dissolution Studies in Biorelevant Media , 2002, Pharmaceutical Research.

[27]  Bertil Abrahamsson,et al.  Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  L. Gladden,et al.  In vitro quantitative ((1))H and ((19))F nuclear magnetic resonance spectroscopy and imaging studies of fluvastatin™ in Lescol® XL tablets in a USP-IV dissolution cell. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[29]  P. Armenante,et al.  A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms. , 2012, Journal of pharmaceutical sciences.

[30]  Nikoletta Fotaki,et al.  Biorelevant dissolution: Methodology and application in drug development , 2009 .

[31]  Y. Ozaki,et al.  Release mechanisms of acetaminophen from polyethylene oxide/polyethylene glycol matrix tablets utilizing magnetic resonance imaging. , 2010, International journal of pharmaceutics.

[32]  F. Muzzio,et al.  Shear-induced variability in the United States pharmacopeia apparatus 2: Modifications to the existing system , 2005, The AAPS Journal.

[33]  S. Qureshi Comparative Impact of Stirring and Shearing in Drug Dissolution Testing with USP Paddle and Crescent-Shaped Spindles , 2006 .

[34]  J. Dressman,et al.  Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine , 2004, The Journal of pharmacy and pharmacology.

[35]  M. Brewster,et al.  Supersaturating drug delivery systems: fast is not necessarily good enough. , 2012, Journal of pharmaceutical sciences.

[36]  A J Sederman,et al.  MRI studies of the hydrodynamics in a USP 4 dissolution testing cell. , 2011, Journal of pharmaceutical sciences.

[37]  Makoto Kataoka,et al.  In vitro dissolution/permeation system to predict the oral absorption of poorly water-soluble drugs: effect of food and dose strength on it. , 2011, Biological & pharmaceutical bulletin.

[38]  P. Quist,et al.  Dissolution of USP prednisone calibrator tablets: effects of stirring conditions and particle size distribution. , 2003, Journal of pharmaceutical and biomedical analysis.

[39]  James A. Rogers,et al.  Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. I. Description of a two-phase in vitro dissolution test , 1997 .

[40]  Christopher S. Polster,et al.  Use of artificial stomach-duodenum model for investigation of dosing fluid effect on clinical trial variability. , 2010, Molecular pharmaceutics.

[41]  J. Dressman,et al.  An In Vitro Methodology for Forecasting Luminal Concentrations and Precipitation of Highly Permeable Lipophilic Weak Bases in the Fasted Upper Small Intestine , 2012, Pharmaceutical Research.

[42]  Clive G. Wilson,et al.  Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[43]  P. Kulinowski,et al.  Novel Application of MRI Technique Combined with Flow-Through Cell Dissolution Apparatus as Supportive Discriminatory Test for Evaluation of Controlled Release Formulations , 2010, AAPS PharmSciTech.

[44]  M. Wickham,et al.  The Design, Operation, and Application of a Dynamic Gastric Model , 2012 .

[45]  J. Dressman,et al.  Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. , 1997, Advanced drug delivery reviews.

[46]  W. Weitschies,et al.  A biorelevant dissolution stress test device – background and experiences , 2010, Expert opinion on drug delivery.

[47]  D. J. Phillips,et al.  Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems , 2012, The Journal of pharmacy and pharmacology.

[48]  Monique Alric,et al.  Investigation of the Biopharmaceutical Behavior of Theophylline Hydrophilic Matrix Tablets Using USP Methods and an Artificial Digestive System , 2007, Drug development and industrial pharmacy.

[49]  Werner Weitschies,et al.  Investigation of the Dissolution Characteristics of Nifedipine Extended-Release Formulations Using USP Apparatus 2 and a Novel Dissolution Apparatus , 2009 .